口腔癌向治疗的进展:一个小小的回顾
Sakshi G Ingole1, Ashwini A Aher2, Sunil N Thitame3
1Biomedical Sciences, School of Allied Health Science, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India.
Journal of pharmacy & bioallied sciences
|June 13, 2025
概括
向疗法通过向分子瘤特征来彻底改变口腔癌治疗. 在EGFR抑制剂,免疫检查点抑制剂和组合疗法方面的进展提供了更好的疗效和患者的生活质量.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 口腔癌的治疗传统上依赖于手术,放射和化疗.
- 新兴的向疗法通过专注于特定的分子瘤特征来提供精确治疗.
- 这些新的方法旨在提高治疗的准确性,并尽量减少对健康组织的损伤.
研究的目的:
- 审查目前针对口腔癌的向治疗方法的进展.
- 探索针对性疗法与传统治疗方式的整合.
- 突出个性化医学的潜力,提高治疗结果和患者生存率.
主要方法:
- 对针对性口腔癌治疗的最新研究的文献综述.
- 对表皮生长因子受体 (EGFR) 抑制剂的临床数据的分析.
- 检查免疫检查点抑制剂和其他生物标志物导向治疗的检查.
- 讨论涉及向药物和传统治疗的组合策略.
主要成果:
- 包括EGFR抑制剂和免疫检查点抑制剂在内的向疗法在口腔癌管理中显示出前途.
- 结合疗法将向药物与手术,放射和化疗相结合,提高治疗效率.
- 生物标志物药物导向策略对于个性化治疗方法至关重要.
- 个性化医学在克服药物耐药性和改善患者预后方面显示出潜力.
结论:
- 向疗法代表了口腔癌治疗的重大进步,提供了精确性和更好的结果.
- 将向疗法与传统方法相结合,可以提高疗效和患者的存活率.
- 个性化医疗方法为改善口腔癌患者的生活质量提供了光明的未来.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:30Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K